{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:07:45Z","timestamp":1774897665699,"version":"3.50.1"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","award":["G2020000360 Drews"],"award-info":[{"award-number":["G2020000360 Drews"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","award":["G2020000360 Drews"],"award-info":[{"award-number":["G2020000360 Drews"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","award":["G2020000360 Drews"],"award-info":[{"award-number":["G2020000360 Drews"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","award":["G2020000360 Drews"],"award-info":[{"award-number":["G2020000360 Drews"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","award":["G2020000360 Drews"],"award-info":[{"award-number":["G2020000360 Drews"]}],"id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR2-172723"],"award-info":[{"award-number":["VR2-172723"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR2-172723"],"award-info":[{"award-number":["VR2-172723"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR2-172723"],"award-info":[{"award-number":["VR2-172723"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR2-172723"],"award-info":[{"award-number":["VR2-172723"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR2-172723"],"award-info":[{"award-number":["VR2-172723"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,10,26]]},"abstract":"<jats:p>The United States Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the use of COVID-19 convalescent plasma (CCP) to treat hospitalized patients with COVID-19 in August 2020. However, by 4 February 2021, the FDA had revised the convalescent plasma EUA.<\/jats:p>","DOI":"10.1128\/spectrum.02811-22","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T13:06:44Z","timestamp":1663679204000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses"],"prefix":"10.1128","volume":"10","author":[{"given":"Yi-Chan J.","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology &amp; Immunology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-299X","authenticated-orcid":true,"given":"David H.","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology &amp; Immunology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninette F.","family":"Robbins","sequence":"additional","affiliation":[{"name":"Scientific Affairs, Abbott Transfusion Medicine, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Orjuela","sequence":"additional","affiliation":[{"name":"Scientific Affairs, Abbott Transfusion Medicine, Bogot\u00e1, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Queenie","family":"Hu","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuben","family":"Samson","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"},{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kento T.","family":"Abe","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"},{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavisha","family":"Rathod","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Colwill","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Claude","family":"Gingras","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"},{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashleigh","family":"Tuite","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Long","family":"Yi","sequence":"additional","affiliation":[{"name":"Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-2789","authenticated-orcid":true,"given":"Sheila F.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-1109","authenticated-orcid":true,"given":"Steven J.","family":"Drews","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Microbiology, Edmonton, Alberta, Canada"},{"name":"Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"National Institutes of Health. 16 December 2021. Coronavirus disease 2019 (COVID-19) treatment guidelines. https:\/\/www.covid19treatmentguidelines.nih.gov\/. Accessed 16 August 2022."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16364"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142362"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18178"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01488-2"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16713"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02262-21"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.13042"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.47375"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119657"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09218-5"},{"key":"e_1_3_3_13_2","volume-title":"SARS-CoV-2 IgG II Quant, Architect.","author":"Abbott","year":"2020","unstructured":"Abbott. 2020. SARS-CoV-2 IgG II Quant, Architect. Package insert. Abbott, Chicago, IL."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2021.1974540"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/20587384211073232"},{"key":"e_1_3_3_16_2","first-page":"265","article-title":"Anti-SARS-CoV-2 antibodies persistence after natural infection: a repeated serosurvey in Northern Italy","volume":"57","author":"Fedele G","year":"2021","unstructured":"Fedele G, Stefanelli P, Bella A, Fiore S, Pancheri S, Benedetti E, Fabiani C, Leone P, Vacca P, Schiavoni I, Neri A, Carannante A, Simmaco M, Santino I, Zuccali MG, Bizzarri G, Magnoni R, Benetollo PP, Brusaferro S, Rezza G, Ferro A. 2021. Anti-SARS-CoV-2 antibodies persistence after natural infection: a repeated serosurvey in Northern Italy. Ann Ist Super Sanita 57:265\u2013271.","journal-title":"Ann Ist Super Sanita"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2021.2025421"},{"key":"e_1_3_3_18_2","unstructured":"National Collaborating Centre for Infectious Diseases. 2021. Updates on COVID-19 variants of concern. https:\/\/nccid.ca\/covid-19-variants\/#subMenuSection0. Accessed 16 August 2022."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00247-21"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02563-21"},{"key":"e_1_3_3_21_2","unstructured":"Government of Canada. 2021. COVID-19 vaccination in Canada. 2021. https:\/\/health-infobase.canada.ca\/covid-19\/vaccination-coverage\/. Accessed 16 August 2022."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02030-21"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16772"},{"key":"e_1_3_3_24_2","unstructured":"Canadian Blood Services. 2022. COVID-19 seroprevalence brief report. https:\/\/www.covid19immunitytaskforce.ca\/wp-content\/uploads\/2022\/06\/covid-19-brief-report-may-2022-june-12-2022.pdf. Accessed 16 August 2022."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.31.2200561"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101576"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01163-3"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02702-21"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16934"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071101"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2022.103513"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.07.009"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.17020"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.159721"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32235-x"},{"key":"e_1_3_3_36_2","unstructured":"Canadian Blood Services. 2021. Surveillance report. https:\/\/professionaleducation.blood.ca\/en\/transfusion\/publications\/surveillance-report. Accessed 16 August 2022."},{"key":"e_1_3_3_37_2","first-page":"10","article-title":"Waning anti-nucleocapsid IgG signal among SARS-CoV-2 seropositive blood donors: May\u2013November 2020","volume":"6","author":"Saeed S","year":"2021","unstructured":"Saeed S, Drews SJ, Pambrun C, O'Brien SF. 2021. Waning anti-nucleocapsid IgG signal among SARS-CoV-2 seropositive blood donors: May\u2013November 2020. JAMMI 6:10\u201311.","journal-title":"JAMMI"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257743"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02811-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02811-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T13:57:03Z","timestamp":1666792623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.02811-22"}},"subtitle":[],"editor":[{"given":"Heba H.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10,26]]}},"alternative-id":["10.1128\/spectrum.02811-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.02811-22","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"2022-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02811-22"}}